Global Biosimilar Insulin Lispro Market Growth 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biosimilar Insulin Lispro Consumption 2016-2026

2.1.2 Biosimilar Insulin Lispro Consumption CAGR by Region

2.2 Biosimilar Insulin Lispro Segment by Type

2.2.1 Pre-filled

2.2.2 Cartridge

2.3 Biosimilar Insulin Lispro Sales by Type

2.3.1 Global Biosimilar Insulin Lispro Sales Market Share by Type (2016-2021)

2.3.2 Global Biosimilar Insulin Lispro Revenue and Market Share by Type (2016-2021)

2.3.3 Global Biosimilar Insulin Lispro Sale Price by Type (2016-2021)

2.4 Biosimilar Insulin Lispro Segment by Application

2.4.1 Hospital

2.4.2 Retail Pharmacy

2.4.3 Others

2.5 Biosimilar Insulin Lispro Sales by Application

2.5.1 Global Biosimilar Insulin Lispro Sale Market Share by Application (2016-2021)

2.5.2 Global Biosimilar Insulin Lispro Revenue and Market Share by Application (2016-2021)

2.5.3 Global Biosimilar Insulin Lispro Sale Price by Application (2016-2021)

3 Global Biosimilar Insulin Lispro by Company

3.1 Global Biosimilar Insulin Lispro Sales Market Share by Company

3.1.1 Global Biosimilar Insulin Lispro Sales by Company (2019-2021)

3.1.2 Global Biosimilar Insulin Lispro Sales Market Share by Company (2019-2021)

3.2 Global Biosimilar Insulin Lispro Revenue Market Share by Company

3.2.1 Global Biosimilar Insulin Lispro Revenue by Company (2019-2021)

3.2.2 Global Biosimilar Insulin Lispro Revenue Market Share by Company (2019-2021)

3.3 Global Biosimilar Insulin Lispro Sale Price by Company

3.4 Global Manufacturers Biosimilar Insulin Lispro Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Biosimilar Insulin Lispro Product Location Distribution

3.4.2 Players Biosimilar Insulin Lispro Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Biosimilar Insulin Lispro by Region

4.1 Global Biosimilar Insulin Lispro by Region

4.1.1 Global Biosimilar Insulin Lispro Sales by Region

4.1.2 Global Biosimilar Insulin Lispro Revenue by Region

4.2 Americas Biosimilar Insulin Lispro Sales Growth

4.3 APAC Biosimilar Insulin Lispro Sales Growth

4.4 Europe Biosimilar Insulin Lispro Sales Growth

4.5 Middle East & Africa Biosimilar Insulin Lispro Sales Growth

5 Americas

5.1 Americas Biosimilar Insulin Lispro Sales by Country

5.1.1 Americas Biosimilar Insulin Lispro Sales by Country (2016-2021)

5.1.2 Americas Biosimilar Insulin Lispro Revenue by Country (2016-2021)

5.2 Americas Biosimilar Insulin Lispro Sales by Type

5.3 Americas Biosimilar Insulin Lispro Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biosimilar Insulin Lispro Sales by Region

6.1.1 APAC Biosimilar Insulin Lispro Sales by Region (2016-2021)

6.1.2 APAC Biosimilar Insulin Lispro Revenue by Region (2016-2021)

6.2 APAC Biosimilar Insulin Lispro Sales by Type

6.3 APAC Biosimilar Insulin Lispro Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Biosimilar Insulin Lispro by Country

7.1.1 Europe Biosimilar Insulin Lispro Sales by Country (2016-2021)

7.1.2 Europe Biosimilar Insulin Lispro Revenue by Country (2016-2021)

7.2 Europe Biosimilar Insulin Lispro Sales by Type

7.3 Europe Biosimilar Insulin Lispro Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biosimilar Insulin Lispro by Country

8.1.1 Middle East & Africa Biosimilar Insulin Lispro Sales by Country (2016-2021)

8.1.2 Middle East & Africa Biosimilar Insulin Lispro Revenue by Country (2016-2021)

8.2 Middle East & Africa Biosimilar Insulin Lispro Sales by Type

8.3 Middle East & Africa Biosimilar Insulin Lispro Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Biosimilar Insulin Lispro Distributors

10.3 Biosimilar Insulin Lispro Customer

11 Global Biosimilar Insulin Lispro Market Forecast

11.1 Global Biosimilar Insulin Lispro Forecast by Region

11.1.1 Global Biosimilar Insulin Lispro Forecast by Regions (2021-2026)

11.2.2 Global Biosimilar Insulin Lispro Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Biosimilar Insulin Lispro Forecast by Type

11.7 Global Biosimilar Insulin Lispro Forecast by Application

12 Key Players Analysis

12.1 Sanofi

12.1.1 Sanofi Company Information

12.1.2 Sanofi Biosimilar Insulin Lispro Product Offered

12.1.3 Sanofi Biosimilar Insulin Lispro Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Sanofi Main Business Overview

12.1.5 Sanofi Latest Developments

12.2 Gan&Lee

12.2.1 Gan&Lee Company Information

12.2.2 Gan&Lee Biosimilar Insulin Lispro Product Offered

12.2.3 Gan&Lee Biosimilar Insulin Lispro Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Gan&Lee Main Business Overview

12.2.5 Gan&Lee Latest Developments

12.3 Geropharm

12.3.1 Geropharm Company Information

12.3.2 Geropharm Biosimilar Insulin Lispro Product Offered

12.3.3 Geropharm Biosimilar Insulin Lispro Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Geropharm Main Business Overview

12.3.5 Geropharm Latest Developments

13 Research Findings and Conclusion

Table 1. Biosimilar Insulin Lispro Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Pre-filled

Table 3. Major Players of Cartridge

Table 4. Global Biosimilar Insulin Lispro Sales by Type (2016-2021) & (K Units)

Table 5. Global Biosimilar Insulin Lispro Sales Market Share by Type (2016-2021)

Table 6. Global Biosimilar Insulin Lispro Revenue by Type (2016-2021) & ($ million)

Table 7. Global Biosimilar Insulin Lispro Revenue Market Share by Type (2016-2021)

Table 8. Global Biosimilar Insulin Lispro Sale Price by Type (2016-2021)

Table 9. Global Biosimilar Insulin Lispro Sales by Application (2016-2021) & (K Units)

Table 10. Global Biosimilar Insulin Lispro Sales Market Share by Application (2016-2021)

Table 11. Global Biosimilar Insulin Lispro Value by Application (2016-2021)

Table 12. Global Biosimilar Insulin Lispro Revenue Market Share by Application (2016-2021)

Table 13. Global Biosimilar Insulin Lispro Sale Price by Application (2016-2021)

Table 14. Global Biosimilar Insulin Lispro Sales by Company (2019-2021) & (K Units)

Table 15. Global Biosimilar Insulin Lispro Sales Market Share by Company (2019-2021)

Table 16. Global Biosimilar Insulin Lispro Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Biosimilar Insulin Lispro Revenue Market Share by Company (2019-2021)

Table 18. Global Biosimilar Insulin Lispro Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Biosimilar Insulin Lispro Producing Area Distribution and Sales Area

Table 20. Players Biosimilar Insulin Lispro Products Offered

Table 21. Biosimilar Insulin Lispro Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Biosimilar Insulin Lispro Sales by Region (2016-2021) (K Units)

Table 25. Global Biosimilar Insulin Lispro Sales Market Share by Region (2016-2021)

Table 26. Global Biosimilar Insulin Lispro Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Biosimilar Insulin Lispro Revenue Market Share by Region (2016-2021)

Table 28. Americas Biosimilar Insulin Lispro Sales by Country (2016-2021) & (K Units)

Table 29. Americas Biosimilar Insulin Lispro Sales Market Share by Country (2016-2021)

Table 30. Americas Biosimilar Insulin Lispro Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Biosimilar Insulin Lispro Revenue Market Share by Country (2016-2021)

Table 32. Americas Biosimilar Insulin Lispro Sales by Type (2016-2021) & (K Units)

Table 33. Americas Biosimilar Insulin Lispro Sales Market Share by Type (2016-2021)

Table 34. Americas Biosimilar Insulin Lispro Sales by Application (2016-2021) & (K Units)

Table 35. Americas Biosimilar Insulin Lispro Sales Market Share by Application (2016-2021)

Table 36. APAC Biosimilar Insulin Lispro Sales by Region (2016-2021) & (K Units)

Table 37. APAC Biosimilar Insulin Lispro Sales Market Share by Region (2016-2021)

Table 38. APAC Biosimilar Insulin Lispro Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Biosimilar Insulin Lispro Revenue Market Share by Region (2016-2021)

Table 40. APAC Biosimilar Insulin Lispro Sales by Type (2016-2021) & (K Units)

Table 41. APAC Biosimilar Insulin Lispro Sales Market Share by Type (2016-2021)

Table 42. APAC Biosimilar Insulin Lispro Sales by Application (2016-2021) & (K Units)

Table 43. APAC Biosimilar Insulin Lispro Sales Market Share by Application (2016-2021)

Table 44. Europe Biosimilar Insulin Lispro Sales by Country (2016-2021) & (K Units)

Table 45. Europe Biosimilar Insulin Lispro Sales Market Share by Country (2016-2021)

Table 46. Europe Biosimilar Insulin Lispro Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Biosimilar Insulin Lispro Revenue Market Share by Country (2016-2021)

Table 48. Europe Biosimilar Insulin Lispro Sales by Type (2016-2021) & (K Units)

Table 49. Europe Biosimilar Insulin Lispro Sales Market Share by Type (2016-2021)

Table 50. Europe Biosimilar Insulin Lispro Sales by Application (2016-2021) & (K Units)

Table 51. Europe Biosimilar Insulin Lispro Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Biosimilar Insulin Lispro Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Biosimilar Insulin Lispro Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Biosimilar Insulin Lispro Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Biosimilar Insulin Lispro Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Biosimilar Insulin Lispro Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Biosimilar Insulin Lispro Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Biosimilar Insulin Lispro Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Biosimilar Insulin Lispro Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Biosimilar Insulin Lispro

Table 61. Key Application and Potential Industries of Biosimilar Insulin Lispro

Table 62. Key Challenges of Biosimilar Insulin Lispro

Table 63. Key Trends of Biosimilar Insulin Lispro

Table 64. Biosimilar Insulin Lispro Distributors List

Table 65. Biosimilar Insulin Lispro Customer List

Table 66. Global Biosimilar Insulin Lispro Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Biosimilar Insulin Lispro Consumption Market Forecast by Region

Table 68. Global Biosimilar Insulin Lispro Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Biosimilar Insulin Lispro Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Biosimilar Insulin Lispro Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Biosimilar Insulin Lispro Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Biosimilar Insulin Lispro Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Biosimilar Insulin Lispro Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Biosimilar Insulin Lispro Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Biosimilar Insulin Lispro Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Biosimilar Insulin Lispro Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Biosimilar Insulin Lispro Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Biosimilar Insulin Lispro Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Biosimilar Insulin Lispro Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Biosimilar Insulin Lispro Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Biosimilar Insulin Lispro Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Biosimilar Insulin Lispro Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Biosimilar Insulin Lispro Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Biosimilar Insulin Lispro Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Biosimilar Insulin Lispro Revenue Market Share Forecast by Application (2021-2026)

Table 86. Sanofi Basic Information, Biosimilar Insulin Lispro Manufacturing Base, Sales Area and Its Competitors

Table 87. Sanofi Biosimilar Insulin Lispro Product Offered

Table 88. Sanofi Biosimilar Insulin Lispro Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. Sanofi Main Business

Table 90. Sanofi Latest Developments

Table 91. Gan&Lee Basic Information, Biosimilar Insulin Lispro Manufacturing Base, Sales Area and Its Competitors

Table 92. Gan&Lee Biosimilar Insulin Lispro Product Offered

Table 93. Gan&Lee Biosimilar Insulin Lispro Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. Gan&Lee Main Business

Table 95. Gan&Lee Latest Developments

Table 96. Geropharm Basic Information, Biosimilar Insulin Lispro Manufacturing Base, Sales Area and Its Competitors

Table 97. Geropharm Biosimilar Insulin Lispro Product Offered

Table 98. Geropharm Biosimilar Insulin Lispro Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. Geropharm Main Business

Table 100. Geropharm Latest Developments

List of Figures

Figure 1. Picture of Biosimilar Insulin Lispro

Figure 2. Biosimilar Insulin Lispro Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Biosimilar Insulin Lispro Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Biosimilar Insulin Lispro Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Biosimilar Insulin Lispro Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Pre-filled

Figure 10. Product Picture of Cartridge

Figure 11. Global Biosimilar Insulin Lispro Sales Market Share by Type in 2020

Figure 12. Global Biosimilar Insulin Lispro Revenue Market Share by Type (2016-2021)

Figure 13. Biosimilar Insulin Lispro Consumed in Hospital

Figure 14. Global Biosimilar Insulin Lispro Market: Hospital (2016-2021) & (K Units)

Figure 15. Biosimilar Insulin Lispro Consumed in Retail Pharmacy

Figure 16. Global Biosimilar Insulin Lispro Market: Retail Pharmacy (2016-2021) & (K Units)

Figure 17. Biosimilar Insulin Lispro Consumed in Others

Figure 18. Global Biosimilar Insulin Lispro Market: Others (2016-2021) & (K Units)

Figure 19. Global Biosimilar Insulin Lispro Sales Market Share by Application (2016-2021)

Figure 20. Global Biosimilar Insulin Lispro Revenue Market Share by Application in 2020

Figure 21. Biosimilar Insulin Lispro Revenue Market by Company in 2020 ($ Million)

Figure 22. Global Biosimilar Insulin Lispro Revenue Market Share by Company in 2020

Figure 23. Global Biosimilar Insulin Lispro Sales Market Share by Regions (2016-2021)

Figure 24. Global Biosimilar Insulin Lispro Revenue Market Share by Region in 2020

Figure 25. Americas Biosimilar Insulin Lispro Sales 2016-2021 (K Units)

Figure 26. Americas Biosimilar Insulin Lispro Revenue 2016-2021 ($ Millions)

Figure 27. APAC Biosimilar Insulin Lispro Sales 2016-2021 (K Units)

Figure 28. APAC Biosimilar Insulin Lispro Revenue 2016-2021 ($ Millions)

Figure 29. Europe Biosimilar Insulin Lispro Sales 2016-2021 (K Units)

Figure 30. Europe Biosimilar Insulin Lispro Revenue 2016-2021 ($ Millions)

Figure 31. Middle East & Africa Biosimilar Insulin Lispro Sales 2016-2021 (K Units)

Figure 32. Middle East & Africa Biosimilar Insulin Lispro Revenue 2016-2021 ($ Millions)

Figure 33. Americas Biosimilar Insulin Lispro Sales Market Share by Country in 2020

Figure 34. Americas Biosimilar Insulin Lispro Revenue Market Share by Country in 2020

Figure 35. Americas Biosimilar Insulin Lispro Sales Market Share by Type in 2020

Figure 36. Americas Biosimilar Insulin Lispro Sales Market Share by Application in 2020

Figure 37. United States Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 38. Canada Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 39. Mexico Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 40. Brazil Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 41. APAC Biosimilar Insulin Lispro Sales Market Share by Region in 2020

Figure 42. APAC Biosimilar Insulin Lispro Revenue Market Share by Regions in 2020

Figure 43. APAC Biosimilar Insulin Lispro Sales Market Share by Type in 2020

Figure 44. APAC Biosimilar Insulin Lispro Sales Market Share by Application in 2020

Figure 45. China Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 46. Japan Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 47. Korea Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 48. Southeast Asia Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 49. India Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 50. Australia Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 51. Europe Biosimilar Insulin Lispro Sales Market Share by Country in 2020

Figure 52. Europe Biosimilar Insulin Lispro Revenue Market Share by Country in 2020

Figure 53. Europe Biosimilar Insulin Lispro Sales Market Share by Type in 2020

Figure 54. Europe Biosimilar Insulin Lispro Sales Market Share by Application in 2020

Figure 55. Germany Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 56. France Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 57. UK Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 58. Italy Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 59. Russia Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 60. Middle East & Africa Biosimilar Insulin Lispro Sales Market Share by Country in 2020

Figure 61. Middle East & Africa Biosimilar Insulin Lispro Revenue Market Share by Country in 2020

Figure 62. Middle East & Africa Biosimilar Insulin Lispro Sales Market Share by Type in 2020

Figure 63. Middle East & Africa Biosimilar Insulin Lispro Sales Market Share by Application in 2020

Figure 64. Egypt Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 65. South Africa Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 66. Israel Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 67. Turkey Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 68. GCC Country Biosimilar Insulin Lispro Revenue Growth 2016-2021 ($ Millions)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles